Pfizer&#39;s Lipitor Lowers Heart Risk for Diabetics, Lancet Says
609249
Aug. 20 (Bloomberg) -- Pfizer Inc.&#39;s Lipitor cholesterol reducer, the world&#39;s top-selling drug, cut heart attacks and strokes by more than a third for diabetics who didn&#39;t start out with high levels of so-called bad cholesterol, the British medical ...
534985
Early results from a new study of GlaxoSmithKline Plc's diabetes drug Avandia showed no difference in the risk of heart problems between patients taking the controversial drug and those who took other diabetes drugs, researchers said on Tuesday.
237438
A Takeda Pharmaceuticals diabetes  drug was more effective in dealing with patients' cholesterol  problems than one made by GlaxoSmithKline in a head-to-head  study presented on Wednesday.
325021
NEW YORK  - New research suggests that all patients who undergo angioplasty should receive cholesterol-lowering &quot;statin&quot; drugs, such as Zocor and Lipitor (news - web sites).
540596
TUESDAY, Dec. 18 (HealthDay News) -- A new kind of drug designed to lower levels of "bad" low-density lipoprotein (LDL) cholesterol and reduce heart disease risk has proved safe and effective in a phase II clinical trial, researchers report.
646726
NEW YORK  - Early treatment with Lipitor  (atorvastatin), a "statin" cholesterol-lowering drug, reduces  the build-up of artery-clogging plaque in patients who've had a  recent heart attack, new research suggests.
389313
Diabetics should receive cholesterol-busting drugs regardless of their heart disease risk, researchers say.
723553
The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows.
516107
WASHINGTON - GlaxoSmithKline PLC's Avandia, the world's best-selling diabetes drug last year, will carry US regulators' strongest warning on the risk of heart attacks.
477879
The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it also carries an increased risk of nonfatal heart failure, the analysis showed, confirming earlier studies.
344953
NEW YORK  - When administered at doses that lower lipid levels, atorvastatin, sold in the U.S. under the trade name Lipitor, appears to have no effect on bone mineral density or bone metabolism in postmenopausal women, according to researchers.
386541
Diabetics can prevent heart disease and live longer by taking the anti-cholesterol drug Atorvastatin, even if they do not have particularly high cholesterol levels, a study published on Friday said.
114045
The diabetes drugs Actos and Avandia raise the risk of heart failure but do not increase the risk of heart-related death, U.S. researchers said on Thursday, confirming earlier findings.
143479
AstraZeneca Plc's cholesterol-lowering  drug Crestor performed better than Pfizer Inc's Lipitor in an  AstraZeneca-funded study of patients with metabolic syndrome,  according to results released on Monday.
71640
NEW YORK  - Daily aspirin is usually recommended for people at increased risk for heart disease, and people with diabetes come into that category.
641620
Cholesterol-regulating statin drugs slightly lower the risk of heart attack and stroke in people with no history of cardiovascular disease but may do little to reduce their risk of death, a new analysis concluded on Monday.
239851
NEW ORLEANS  - Cholesterol-lowering  'statin' drugs -- such as Lipitor or Zocor, for example -- also  lower blood pressure to a modest extent, according to a report  at the American Heart Association annual meeting.